The main differential diagnosis of this LMNA-NTRK1 fusion tumor was IMT because of prominent inflammatory cells in the tumor, but it can be ruled out based on its immunoprofile (SMA-negative, with S100/CD34 coexpression). The gene discussed is SMN1; the disease is inflammatory myofibroblastic tumor.